Genetic associations of hemoglobin in children with chronic kidney disease in the PediGFR Consortium

Meredith A Atkinson, Rui Xiao, Anna Köttgen, Elke Wühl, Craig S Wong, Matthias Wuttke, Aysun K Bayazit, Salim Çalişkan, Bradley A Warady, Franz Schaefer, Susan L Furth, Meredith A Atkinson, Rui Xiao, Anna Köttgen, Elke Wühl, Craig S Wong, Matthias Wuttke, Aysun K Bayazit, Salim Çalişkan, Bradley A Warady, Franz Schaefer, Susan L Furth

Abstract

Background: Genome-wide association studies (GWAS) in healthy populations have identified variants associated with erythrocyte traits, but genetic causes of hemoglobin variation in children with CKD are incompletely understood.

Methods: The Pediatric Investigation of Genetic Factors Linked with Renal Progression (PediGFR) Consortium comprises three pediatric CKD cohorts: Chronic Kidney Disease in Children (CKiD), Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE), and Cardiovascular Comorbidity in Children with CKD (4C). We performed cross-sectional and longitudinal association studies of single-nucleotide polymorphisms (SNPs) in 1125 patients.

Results: Children of European (n = 725) or Turkish (n = 400) ancestry (EA or TA) were included. In cross-sectional analysis, two SNPs (rs10758658 and rs12718597) previously associated with RBC traits were significantly associated with hemoglobin levels in children of EA and TA. In longitudinal analysis, SNP rs2540917 was nominally associated with hemoglobin in EA and TA children.

Conclusions: SNPs associated with erythrocyte traits in healthy populations were marginally significant for an association with hemoglobin. Further analyses/replication studies are needed in larger CKD cohorts to investigate SNPs of unknown significance associated with hemoglobin. Functional studies will be required to confirm that the observed associations between SNPs and clinical phenotype are causal.

References

    1. Atkinson MA, Furth SL. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011; 7(11): 635–641.
    1. Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008; 3(2): 457–462.
    1. Borzych-Duzalka D, Bilginer Y, Ha IS, et al. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 2013; 24(4): 665–676.
    1. Atkinson MA, Pierce CB, Zack RM, et al. Hemoglobin differences by race in children with CKD. Am J Kidney Dis 2010; 55(6): 1009–1017.
    1. Robins EB, Blum S. Hematologic reference values for African American children and adolescents. Am J Hematol 2007; 82(7): 611–614.
    1. Ganesh SK, Zakai NA, van Rooij FJ, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009; 41(11): 1191–1198.
    1. Li J, Glessner JT, Zhang H, et al. GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American Children. Hum Mol Genet 2013; 22(7): 1457–1464.
    1. Ding K, de Andrade M, Manolio TA, et al. Genetic variants that confer resistance to malaria are associated with red blood cell traits in African-Americans: an electronic medical record-based genome-wide association study. G3 (Bethesda) 2013; 3(7): 1061–1068.
    1. Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol 2010; 25(9): 1699–1706.
    1. Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361(21): 2019–2032.
    1. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355(20): 2085–2098.
    1. Lestz RM, Fivush BA, Atkinson MA. Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis. Pediatr Nephrol 2014; 29(10): 2021–2028.
    1. Wuttke M, Wong CS, Wühl E, et al. Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium. Nephrol Dial Transplant 2016; 31(2): 262–269.
    1. Gupta J, Kanetsky PA, Wuttke M, Köttgen A, Schaefer F, Wong CS. Genome-wide association studies in pediatric chronic kidney disease. Pediatr Nephrol 2016; 31(8): 1241–1252.
    1. Furth SL, Cole SR, Moxey-Mims M, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2006; 1(5): 1006–1015.
    1. ESCAPE Trial Group, Wühl E, Trivelli A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361(17): 1639–1650.
    1. Querfeld U, Anarat A, Bayazit AK, et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 2010; 5(9): 1642–1648.
    1. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010; 11(7): 499–511.
    1. Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013; 10(1): 5–6.
    1. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5(6): e1000529.
    1. 1000 Genomes Project Consortium Abecasis GR, Auton A, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491(7422): 56–65.
    1. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20(3): 629–637.
    1. Arnold M, Raffler J, Pfeufer A, Suhre K, Kastenmüller G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics 2015; 31(8): 1334–1336.
    1. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002; 12(6): 996–1006.
    1. Ulirsch JC, Nandakumar SK, Wang L, et al. Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits. Cell 2016; 165(6):1530–1545.
    1. Sarma PR. Red Cell Indices. Walker HK, Hall WD, Hurst JW, ed. Clinical Methods: The History, Physical, and Laboratory Examinations 3rd edition. Boston, Butterworths: 1990; Chapter 152.
    1. Fanis P, Kousiappa I, Phylactides M, Kleanthous M. Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach. BMC Genomics 2014; 15: 108.
    1. Basak A, Sankaran VG. Regulation of the fetal hemoglobin silencing factor BCL11A. Ann NY Acad Sci 2016; 1368(1): 25–30.
    1. Marian AJ. The enigma of genetics etiology of atherosclerosis in the post-GWAS era. Curr Atheroscler Rep 2012; 14(4): 295–299.
    1. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science 2003;302(5646):841.
    1. Tan EK, Tan C, Shen H, Chai A, Lum SY, Teoh ML, Yih Y, Wong MC, Zhao Y. Alpha synuclein promoter and risk of Parkinson’s disease: microsatellite and allelic size variability. Neurosci Lett 32003:36(1):70–72.
    1. Schneider JA, Pungliya MS, Choi JY, Jiang R, Sun XJ, Salisbury BA, Stephens JC. DNA variability of human genes. Mech Ageing Dev 2003;124:17–25.
    1. Nielsen R, Hubisz MJ, Clark AG. Reconstituting the frequency spectrum of ascertained single-nucleotide polymorphism data. Genetics 2004;168:2373–2382.
    1. Lin P-I, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007; 80(3): 531–538.
    1. Amos W, Driscoll E, Hoffman JI. Candidate genes versus genome-wide associations: which are better for detecting genetic susceptibility to infectious disease? Proc Biol Sci 2011;278(1709):1183–1188.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit